← SynDRA
BALOXAVIR MARBOXIL
SynDRA canonical compound SYN0039649 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Mechanism of action | endonuclease inhibitor |
| Indication | influenza A virus infection |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- endonuclease inhibitor
- Inhibitor
- PA INHIBITOR
Drug classes
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- xofluza
- S 033188
- RG 6152
- S-033188
- Xofluza
- UNII-505CXM6OHG
- 505CXM6OHG
- Xofluza (TN)
- Baloxavir marboxil [INN]
- Baloxavir marboxil (JAN/INN)
- SCHEMBL20108731
- EX-A1867
- HY-109025
- CS-0030527
- baloxavirum marboxilum
- RefChem:56255
- J05AX25
- DTXCID301513437
- MFCD31619272
- C27H23F2N3O7S
- Baloxavir marboxil (Standard)
- orb1300991
- BALOXAVIR MARBOXIL [MI]
- BALOXAVIR MARBOXIL [JAN]
- SCHEMBL29350800
- GTPL11748
- BALOXAVIR MARBOXIL [USAN]
- GLXC-20139
- BALOXAVIR MARBOXIL [WHO-DD]
- Baloxavir marboxil (JAN/USAN/INN)
- BDBM50612274
- EBC-27336
- s5952
- AKOS037652423
- DT-0012
- HY-109025R
- BALOXAVIR MARBOXIL [ORANGE BOOK]
Reported adverse events
- Anaphylactic reaction
- Rash
- Sinusitis
- Vomiting
- Bronchitis
- Delirium
- Headache
- Nausea
Look up BALOXAVIR MARBOXIL in the interactive SynDRA portal →